Pituitary apoplexy epidemiology and demographics

Jump to navigation Jump to search

Pituitary apoplexy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pituitary apoplexy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pituitary apoplexy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pituitary apoplexy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pituitary apoplexy epidemiology and demographics

CDC on Pituitary apoplexy epidemiology and demographics

Pituitary apoplexy epidemiology and demographics in the news

Blogs on Pituitary apoplexy epidemiology and demographics

Directions to Hospitals Treating Pituitary apoplexy

Risk calculators and risk factors for Pituitary apoplexy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

The worldwide prevalence of pituitary apoplexy is 6.2 per 100,000 persons. The incidence of pituitary apoplexy is 0.7 per 100,000 persons.[1]

Epidemiology and Demographics

Prevalence

  • Worldwide, the prevalence of pituitary apoplexy is 6.2 per 100,000 persons.[1]

Incidence

  • Worldwide, the incidence of pituitary apoplexy is 0.7 per 100,000 persons.[2]

Age

  • Pituitary apoplexy is commonly seen in adults with a mean age of 57 years.

Gender

  • Males are more commonly affected with pituitary apoplexy than females. Two-thirds of all patients are male.

References

  1. 1.0 1.1 Fernandez A, Karavitaki N, Wass JA (2010). "Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)". Clin Endocrinol (Oxf). 72 (3): 377–82. doi:10.1111/j.1365-2265.2009.03667.x. PMID 19650784.
  2. Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010). "Incidence of pituitary adenomas in Northern Finland in 1992-2007". J Clin Endocrinol Metab. 95 (9): 4268–75. doi:10.1210/jc.2010-0537. PMID 20534753.

Template:WH Template:WS